HORIZON CALL | OPENING

HORIZON CALL | OPENING

From ASPHALION, we would like to inform you of the opening of the call:

HORIZON-HLTH-2021-DISEASE-04-02: Building a European innovation platform for the repurposing of medicinal products

https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-hlth-2021-disease-04-02

This topic aims at supporting activities under the Horizon EU call “Tackling diseases and reducing disease burden”. In particular, it focuses on innovative repurposing strategies of already approved medicinal products and repositioning of investigational products beyond their original indication.

ASPHALION, as SME company, is actively involved in more than 12 EU granted projects as  regulatory expert partners.

Whether you are planning to apply and you would like to add a regulatory partner to the project or if you are interested in knowing more about ASPHALION and our European granted projects expertise, do not hesitate to contact us  at:

horizon@asphalion.com

ASPHALION LISTED TOP PHARMACOVIGILANCE SOLUTIONS PROVIDER IN EUROPE 2021 | INTERVIEW WITH OUR CEO
MEET THE TEAM | RICARD ANDREU, SCIENTIFIC AND REGULATORY AFFAIRS OFFICER